Zipalertinib is an investigational, oral, EGFR tyrosine kinase inhibitor designed to selectively inhibit EGFR variants with ex20ins mutations.
In this study, researchers surveyed nurses at the Turkish Palestinian Friendship Hospital in Gaza about safe ...
A qualitative study evaluated the information-seeking behaviors of patients undergoing genetic testing for hereditary breast cancer.
Angelica” is the name assigned to an AI program deployed last year by Kern Family Health Care, the largest provider of ...
Researchers evaluated a low-dose chemotherapy induction regimen compared with standard-dose therapy in pediatric patients with AML.
In this analysis, researchers analyzed patient-level estimates of cancer-attributable costs based on clinical and ...
In this study, researchers evaluated the germline variants of patients receiving CAR T-cell therapy to screen for the effects of mutations on CAR T-cell behavior in humans.
A contemporary systematic review and meta-analysis of 103 mostly retrospective studies characterized the efficacy and safety of renal tumor biopsy.
Investigators assessed whether acalabrutinib could overcome age-related toxicity limitations that prevented successful combination of ibrutinib with R-CHOP in previously untreated patients with DLBCL.
Accelerated approval is based on objective response rate and duration of response from the phase 2 IGNYTE trial in anti-PD-1-pretreated advanced melanoma.
The latest systematic review on kidney tumor enucleation vs partial nephrectomy includes contemporary robot-assisted series and randomized studies.
In this study, researchers sought to evaluate the sexual health behaviors of young adult cancer survivors and compare them with age-matched individuals from the general population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results